Skip to main content

Table 3 PCR corrected clinical and parasitological failure at day 45 by treatment.

From: Safety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults

Treatment outcome n/N (%) SP AL OR (95% CI) P-value
ETF 25/465 (6.4) 2/462 (0.5) 13.1 (3.08–55.50) <0.001
LCF 33/391 (8.4) 14/404 (3.5) 2.55 (1.34–4.84) 0.004
LPF 18/391 (4.6) 6/404 (1.5) 3.18 (1.25–8.09) 0.02
TTF (PCR corrected) 76/391 (19.3) 22/404 (5.4) 4.15 (2.52–6.83) <0.001
\